A controversial US-funded clinical trial has sparked ethical concerns after experts warned it could withhold life-saving vaccines from thousands of infants, raising questions about the balance between medical research and equitable access to healthcare. Critics argue the study’s design may prioritize scientific data over immediate public health needs, particularly in regions where vaccine shortages already pose severe risks. The debate highlights growing tensions over how experimental treatments are tested when alternatives exist, leaving vulnerable populations in a precarious position. Supporters maintain the trial could yield crucial insights, but opponents demand transparency on how such risks are being justified.
Experts have said the US-funded trial would deny critical vaccines to thousands of infants.
